Trailing-twelve-month (TTM) revenue is $17.00 Billion with a year-over-year growth of +9.68%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,245,421,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $4,146,648,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-24 |
| Q1 FY2026Period ended 2026-03-31 | $4,019,094,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-01 |
| Q2 FY2026Period ended 2026-06-30 | $4,593,416,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $17,004,579,000 |
Current P/S: $15,509,402,889 market capitalization ÷ $17,004,579,000 TTM revenue = 0.91x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.59B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:26.992Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| COLOMBIA | $10.1B | $504M | $404M | $437M | $429M | N/A |
| EGYPT | $4.6B | N/A | N/A |
$17.00B
$17.00 Billion
+9.68%
vs. $15.50B a year ago (TTM)
+3.73%
5 Year compound annual growth rate
1 Year
+9.68%
3 Year
+1.33%
5 Year
+3.73%
10 Year
+36.34%
15 Year
+19.06%
20 Year
+12.74%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $16.13B | +$69.00M | +0.43% |
| 2024 | $16.06B | ($341.00M) | (2.08%) |
| 2023 | $16.40B | +$1.70B | +11.55% |
| 2022 | $14.71B | +$327.00M | +2.27% |
| 2021 | $14.38B | +$1.71B | +13.50% |
| 2020 |
TTM Growth
+9.68%
3-Year CAGR
+1.33%
5-Year CAGR
+3.73%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:26.992Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
| N/A |
| N/A |
| Europe | N/A | N/A | N/A | N/A | N/A | $3.8B |
|---|
| FRANCE | N/A | $869M | $795M | $863M | $781M | N/A |
|---|
| GERMANY | N/A | $464M | N/A | N/A | N/A | N/A |
|---|
| ISRAEL | N/A | N/A | N/A | $785M | $840M | N/A |
|---|
| Middle East and Africa | N/A | N/A | N/A | N/A | N/A | $1.3B |
|---|
| PHILIPPINES | $8.6B | $458M | $398M | $424M | $379M | N/A |
|---|
| UNITED STATES | $72.3B | $3.8B | N/A | N/A | N/A | N/A |
|---|
| $12.67B |
| ($290.00M) |
| (2.24%) |
| 2019 | $12.96B | ($572.00M) | (4.23%) |
| 2018 | $13.53B | +$12.88B | +1979.25% |
| 2017 | $650.76M | +$70.52M | +12.15% |
| 2016 | $580.24M | ($150.87M) | (20.64%) |
